Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Agodoa

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Society of Nephrology : JASN|December 31, 2002
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New ZealandJohn H Stewart, Gherardo Buccianti, Lawrence Agodoa, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)Jennifer J Gassman, Tom Greene, Jackson T Wright, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 21, 2019
Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 StatesGuofen Yan, Jenny I Shen, Rubette Harford, et al.
Ethnicity & Disease|January 24, 2020
The NIDDK High School Short-Term Research Experience for Underrepresented PersonsRobert Rivers, Keith C Norris, George Hui, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2003
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO studyAlfred K Cheung, Nathan W Levin, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney diseaseRichard Haynes, David Lewis, Jonathan Emberson, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung, Michael V Rocco, Guofen Yan, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of the American Society of Nephrology : JASN|December 31, 2002
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New ZealandJohn H Stewart, Gherardo Buccianti, Lawrence Agodoa, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK)Jennifer J Gassman, Tom Greene, Jackson T Wright, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 21, 2019
Racial and Ethnic Variations in Mortality Rates for Patients Undergoing Maintenance Dialysis Treated in US Territories Compared with the US 50 StatesGuofen Yan, Jenny I Shen, Rubette Harford, et al.
Ethnicity & Disease|January 24, 2020
The NIDDK High School Short-Term Research Experience for Underrepresented PersonsRobert Rivers, Keith C Norris, George Hui, et al.
Journal of the American Society of Nephrology : JASN|November 26, 2003
Effects of high-flux hemodialysis on clinical outcomes: results of the HEMO studyAlfred K Cheung, Nathan W Levin, Tom Greene, et al.
Journal of the American Society of Nephrology : JASN|May 3, 2014
Effects of lowering LDL cholesterol on progression of kidney diseaseRichard Haynes, David Lewis, Jonathan Emberson, et al.
Journal of the American Society of Nephrology : JASN|December 31, 2005
Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO studyAlfred K Cheung, Michael V Rocco, Guofen Yan, et al.
Lancet (London, England)|June 14, 2011
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialColin Baigent, Martin J Landray, Christina Reith, et al.
Pageof 3